相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antiviral strategies in hepatitis C virus infection
Christoph Sarrazin et al.
JOURNAL OF HEPATOLOGY (2012)
Understanding silibinin's modes of action against HCV using viral kinetic modeling
Jeremie Guedj et al.
JOURNAL OF HEPATOLOGY (2012)
Silymarin use and liver disease progression in the Hepatitis C Antiviral Long-Term Treatment against Cirrhosis trial
N. D. Freedman et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
RNA-dependent RNA polymerases from different hepatitis C virus genotypes reveal distinct biochemical properties and drug susceptibilities
Marina M. May et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2011)
Effect of Telaprevir on the Pharmacokinetics of Cyclosporine and Tacrolimus
Varun Garg et al.
HEPATOLOGY (2011)
Telaprevir, Boceprevir, Cytochrome P450 and Immunosuppressive Agents - A Potentially Lethal Cocktail
Michael Charlton
HEPATOLOGY (2011)
An Update on Treatment of Genotype 1 Chronic Hepatitis C Virus Infection: 2011 Practice Guideline by the American Association for the Study of Liver Diseases
Marc G. Ghany et al.
HEPATOLOGY (2011)
Silibinin monotherapy prevents graft infection after orthotopic liver transplantation in a patient with chronic hepatitis C
Sandra Beinhardt et al.
JOURNAL OF HEPATOLOGY (2011)
Differential In Vitro Effects of Intravenous versus Oral Formulations of Silibinin on the HCV Life Cycle and Inflammation
Jessica Wagoner et al.
PLOS ONE (2011)
Silibinin and Related Compounds Are Direct Inhibitors of Hepatitis C Virus RNA-Dependent RNA Polymerase
Abdelhakim Ahmed-Belkacem et al.
GASTROENTEROLOGY (2010)
Silymarin Inhibits In Vitro T-Cell Proliferation and Cytokine Production in Hepatitis C Virus Infection
Chihiro Morishima et al.
GASTROENTEROLOGY (2010)
Successful prevention of hepatitis C virus (HCV) liver graft reinfection by silibinin mono-therapy
U. P. Neuman et al.
JOURNAL OF HEPATOLOGY (2010)
Clinical benefits of antiviral therapy in patients with recurrent hepatitis C following liver transplantation
M. Berenguer et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Silibinin Is a Potent Antiviral Agent in Patients With Chronic Hepatitis C Not Responding to Pegylated Interferon/Ribavirin Therapy
Peter Ferenci et al.
GASTROENTEROLOGY (2008)
Herbal product use by persons enrolled in the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial
Leonard B. Seeff et al.
HEPATOLOGY (2008)
Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation
M Berenguer et al.
HEPATOLOGY (2000)
分享论文
